Consumer Goods » Food, Beverages & Tobacco | MYOS RENS Technology Inc.

MYOS RENS Technology Inc. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
4,262.80
4,459.00
5,078.00
4,341.00
4,058.00
3,223
Depreciation, Depletion & Amortization
37.40
204.00
263.00
264.00
318.00
430
Other Funds
1,363.00
2,414.00
1,254.00
426.00
221.00
357
Funds from Operations
2,862.50
1,841.00
3,561.00
3,651.00
3,519.00
2,436
Changes in Working Capital
290.50
3,248.00
1,309.00
22.00
264.00
814
Net Operating Cash Flow
3,153.00
5,089.00
2,252.00
3,673.00
3,783.00
3,250
Capital Expenditures
375.30
29.00
27.00
381.00
2.00
Net Investing Cash Flow
375.30
29.00
27.00
381.00
2.00
Issuance/Reduction of Debt, Net
-
-
675.00
100.00
-
Net Financing Cash Flow
-
6,234.00
1,591.00
5,041.00
2,842.00
Net Change in Cash
3,528.30
1,116.00
688.00
987.00
943.00
Free Cash Flow
3,526.40
5,112.00
2,279.00
3,674.00
3,785.00
Change in Capital Stock
-
6,234.00
916.00
5,141.00
2,842.00

About MYOS RENS Technology

View Profile
Address
45 Horsehill Road
Cedar Knolls New Jersey 07927
United States
Employees -
Website http://www.myosrens.com
Updated 07/08/2019
MYOS RENS Technology, Inc. engages in the discovery, development, and commercialization of therapeutic products, nutritional supplements, and other technologies aimed at improving the health and performance of muscle tissue. It offers bionutrition products and biotherapeutic research. Bionutrition products involves Re Muscle Health, which seeks to rebuild, rejuvenate, and maintain lean muscles.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.